Figure 2.

Overall survival of dogs with mammary carcinomas based on clinical parameters. (A) Percent survival of all female dogs independent of metastasis status. (B) Female dogs with nonmetastatic tumors exhibited increased survival time followed by patients with lung metastasis and lymph node metastasis. (C) Overall survival independent of metastasis status according to tumor grade. Patients with grade III experienced a reduced survival time. (D) Negative correlation between tumor grade and overall survival. Patients with low-grade tumors exhibited increased survival time.